NAD+ 500mg

Overview

NAD+ 500mg is a high-purity research compound widely referenced in scientific and preclinical literature for the study of cellular energy metabolism, redox reactions, and enzymatic processes within controlled laboratory environments. Supplied exclusively for research use, it supports structured experimental workflows focused on compound characterization, assay development, and reproducibility across laboratory studies.

In non-clinical research settings, NAD+ is commonly examined for its involvement in metabolic pathways related to energy transfer, mitochondrial function, and coenzyme-dependent reactions. Researchers may investigate its role in oxidation-reduction processes, substrate-level interactions, and enzymatic activity across various experimental models. In vitro studies often include stability profiling, cofactor interaction analysis, and comparative testing under controlled laboratory conditions.

All information regarding this compound is strictly limited to laboratory-based research. No claims are made regarding therapeutic applications, clinical efficacy, physiological outcomes, or suitability for human or veterinary use.

Key Features

 

• • Research-grade pyridine nucleotide (coenzyme)

 

• • High-purity material suitable for analytical applications

 

• • Lyophilized powder for stability and precise handling

 

• • Widely referenced in cellular metabolism and redox research

 

• • Batch consistency verified through analytical testing methods

 

Biochemical Characteristics

NAD+ 100mg is a research-grade compound widely referenced in scientific literature for its role in cellular energy transfer, redox reactions, and coenzyme-dependent processes within controlled laboratory environments. All characterization of this compound is conducted strictly through physicochemical analysis and standardized research methodologies.

Biochemical evaluation of NAD+ typically includes confirmation of compound identity, purity assessment using advanced chromatographic techniques, and stability testing under controlled laboratory conditions. In preclinical research settings, experimental models may examine its involvement in metabolic pathways related to energy production, mitochondrial activity, and enzymatic reactions. Additional studies often assess compound stability in solution, cofactor functionality, and consistency across in vitro systems to support reliable and reproducible experimental outcomes.

All documentation and evaluation of this compound remain confined to investigational, non-clinical laboratory research.

• • Molecular Class: Pyridine nucleotide (coenzyme)

 

• • Compound Name: Nicotinamide adenine dinucleotide (NAD+)

 

• • Purity: Research-grade, high-purity material

 

• • Material State: Lyophilized powder

 

• • Quantity: 100mg per vial

 

• • Intended Use: Laboratory research only

 

Research Applications

Within scientific and preclinical literature, NAD+ 100mg is referenced as a research compound evaluated exclusively in controlled, non-clinical laboratory environments. Its use is limited to analytical investigation, metabolic pathway studies, and coenzyme-related biochemical research conducted under structured experimental protocols.

Documented laboratory research contexts may include:

• • Cellular energy metabolism studies examining NAD+ involvement in ATP production, mitochondrial function, and electron transfer processes within controlled models

 

• • Redox reaction research focused on NAD+ as a cofactor in oxidation-reduction reactions, supporting enzymatic activity and molecular transformations

 

• • In vitro cellular response modeling within experimental systems designed to observe metabolic activity, signaling pathways, and coenzyme-dependent processes

 

• • Compound stability and integrity testing including evaluation under controlled storage conditions, reconstitution protocols, and experimental environments

 

• • Comparative biochemical research exploring structural and functional relationships between NAD+ and related nucleotides or cofactors

 

• • Analytical benchmarking procedures utilizing validated reference standards, chromatographic verification, and laboratory quality control systems

 

All referenced applications remain strictly confined to laboratory-based investigation and non-clinical experimental use.

Pathway / Mechanistic Context

In experimental and preclinical research literature, NAD+ 500mg is referenced in relation to cellular energy pathways, redox cycling, and coenzyme-dependent biochemical networks examined at the molecular interaction level. These investigations are conducted strictly within controlled laboratory environments.

Scientific discussion often highlights NAD+ within models of metabolic regulation and intracellular energy balance. Mechanistic evaluation may include observation of its role as a cofactor in oxidation-reduction reactions, participation in electron transport processes, and interaction with enzyme systems involved in metabolic cycling. Researchers may also examine its association with mitochondrial activity, substrate conversion, and signaling coordination under controlled in vitro conditions.

All mechanistic interpretations remain observational and exploratory in nature and are confined exclusively to non-clinical research settings.

Preclinical Research Summary

Preclinical research literature references observational findings related to NAD+ 100mg derived from controlled experimental systems designed to evaluate cellular energy metabolism, redox cycling, and coenzyme-dependent processes within non-clinical research frameworks.

Exploratory research discussions often involve evaluation within cellular and biochemical models associated with energy transfer mechanisms, mitochondrial activity, and enzymatic function. Additional analyses may include assessment of compound stability, consistency across experimental replicates, and observation of downstream cellular responses in regulated in vitro systems.

All documented observations remain confined to investigational laboratory contexts and are presented solely for exploratory scientific research purposes.

---

 

Form & Analytical Testing

NAD+ 100mg is supplied as a research-grade compound manufactured under controlled conditions to ensure batch-to-batch consistency, verified identity, and high-purity specifications suitable for laboratory analysis. The material is provided in lyophilized powder form for precise handling and reliable experimental integration.

Analytical evaluation typically includes confirmation of compound identity, purity assessment using high-performance liquid chromatography (HPLC), and molecular mass verification via mass spectrometry. Additional testing includes stability assessment under defined storage and handling conditions.

All testing and validation procedures are conducted exclusively to support material characterization within non-clinical laboratory environments.

Storage & Handling

 

• • Store at low temperature (commonly -20°C)

 

• • Protect from light and moisture

 

• • Reconstitute using sterile laboratory-grade solvents

 

• • Avoid repeated freeze-thaw cycles

 

Referenced Citations

 

• • Ying, W. (2008). NAD+ and NADH in cellular functions and cell death. Frontiers in Bioscience.

 

• • Verdin, E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science.

 

• • Cantó, C., Menzies, K. J., & Auwerx, J. (2015). NAD+ metabolism and the control of energy homeostasis. Nature Reviews Molecular Cell Biology.

 

• • Imai, S., & Guarente, L. (2014). NAD+ and sirtuins in aging and metabolic regulation. Trends in Cell Biology.

 

• • Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic potential of NAD+ boosting molecules. Nature Reviews Drug Discovery.

 

• • Belenky, P., Bogan, K. L., & Brenner, C. (2007). NAD+ metabolism in health and disease. Trends in Biochemical Sciences.

 

• • Houtkooper, R. H., et al. (2010). The secret life of NAD+: An old metabolite controlling new metabolic signaling pathways. Endocrine Reviews.

 

• • Cambronne, X. A., & Kraus, W. L. (2020). Location, location, location: Compartmentalization of NAD+ synthesis and signaling. Trends in Biochemical Sciences.

 

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. FOR RESEARCH USE ONLY (RUO). NOT FOR HUMAN OR VETERINARY USE.

---

 

RUO Disclaimer

All products offered on this website, including NAD+ 100mg, are intended strictly for in vitro laboratory research purposes only. In vitro research refers to experimental procedures conducted outside of living organisms within controlled laboratory environments.

These materials are not classified as drugs, pharmaceuticals, dietary supplements, or medical products. They have not been reviewed, evaluated, or approved by regulatory authorities for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Any use outside structured laboratory research—including administration to humans or animals—is strictly prohibited.

For Laboratory Research Use Only (RUO). Not for human use, medical use, diagnostic use, or veterinary use.